Feb. 27, 2020 |
|
Sept. 28, 2020 |
|
jRCTs031190226 |
A prospective multi-center open trial to evaluate the safety and efficacy of favipiravir in patients infected with COVID-19. |
|
Favipiravir in patients infected with COVID-19 |
Tokue Yutaka |
||
Gunma Universty Hospital |
||
3-39-15 Showa-mchi, Maebashi-shi, Gunma |
||
+81-27-220-8549 |
||
tokue49@gmail.com |
||
Nakamura Tetsuya |
||
Gunma Universty Hospital |
||
3-39-15 Showa-mchi, Maebashi-shi, Gunma |
||
+81-27-220-8740 |
||
nakamurt@gunma-u.ac.jp |
Mar. 14, 2020 |
||
100 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
none |
||
positive result for COVID-19 detection test |
||
pregnancy |
||
20age old over | ||
No limit | ||
Both |
||
patients infected with COVID-19 |
||
oral administration of favipiravir |
||
Coronavirus |
||
expected value and 95% CI of ratio of C-reactive protein before versus after the treatment |
||
disappearance rate of COVID-19 |
Recruiting |
Gunma University Hospital Clinical Research Review Board | |
3-39-15 Showa-mchi, Maebashi-shi, Gunma | |
+81-27-220-8740 |
|
irb-jimukk-ciru@ml.gunma-u.ac.jp | |
Approval | |
Feb. 26, 2020 |